Fire, flood, record-setting heat, hurricanes, tropical storms, earthquakes — we've seen it all in the past several weeks! Natural disasters can present a whole series of unique challenges for people affected by MS.
Last year, I had an opportunity to talk about disaster preparedness for people affected by MS with Mary Casey-Lockyer, the Senior Medical Advisor to Disaster Operations at the American Red Cross. As extreme weather events become a more frequent and regular occurrence in our everyday weather patterns, I thought it might make sense to revisit my conversation with Mary. Mary has just recently retired from her position at the Red Cross, but I think you'll find her tips and strategies as worthwhile and valuable today as they were a year ago.
We'll also tell you about Tyruko, the first biosimilar to receive FDA approval for treating MS (and we'll make sure you know exactly what biosimilars are and where they fit in the spectrum of pharmaceutical treatments).
And we'll share the results of an important clinical trial that may cause experts to re-think when MS begins and when it should be treated.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Revisiting disaster preparedness for people affected by MS :22
The FDA has approved the first biosimilar for treating MS 1:38
Results from a clinical trial show that treating RIS with Aubagio significantly reduces the likelihood of developing MS 4:34
Mary Casey-Lockyer discusses how someone living with MS should prepare for a natural disaster 7:39
Share this episode 28:13
Have you downloaded the free RealTalk MS app? 28:33
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/313
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
STUDY: Teriflunomide and Time to Clinical Multiple Sclerosis in Patients with Radiologically Isolated Syndrome
Join the RealTalk MS Facebook Group
Download the RealTalk MS App for iOS Devices
Download the RealTalk MS App for Android Devices
Give RealTalk MS a rating and review
RealTalk MS Episode 313
Guest: Mary Casey-Lockyer